TME PHARMA - 1H - Technical analysis published on 02/19/2024 (GMT)
- 172
- 0
Oops, I was wrong about that analysis. My threshold for invalidation has been broken.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : INVALID
Analysis too old. There are no more charts available.
Summary of the analysis
Trends
Short term:
Strongly bullish
Underlying:
Strongly bullish
Technical indicators
94%
0%
6%
My opinion
Bullish above 0.3627 EUR
My targets
0.4153 EUR (+12.25%)
0.4847 EUR (+30.99%)
My analysis
All elements being clearly bullish, it would be possible for traders to trade only long positions (at the time of purchase) on TME PHARMA as long as the price remains well above 0.3627 EUR. The buyers' bullish objective is set at 0.4153 EUR. A bullish break in this resistance would boost the bullish momentum. The buyers could then target the resistance located at 0.4847 EUR. If there is any crossing, the next objective would be the resistance located at 1.1100 EUR. However, beware of bullish excesses that could lead to a possible short-term correction; but this possible correction would not be tradeable.
In the very short term, the general bullish sentiment is confirmed by technical indicators. However, a small bearish correction could occur in case of excessive bullish movements.
Force
0
10
9.1
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Londinia. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The TME PHARMA rating is 0.3700 EUR. The price registered an increase of +19.36% on the session and was traded between 0.3050 EUR and 0.3800 EUR over the period. The price is currently at +21.31% from its lowest and -2.63% from its highest.0.3050
0.3800
0.3700
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
New HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
New HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
The Central Volumes scanner notes the presence of abnormal volumes:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
A technical analysis in 1H of this TME PHARMA chart shows a strongly bullish trend. 92.86% of the signals given by moving averages are bullish. This strongly bullish trend is supported by the strong bullish signals given by short-term moving averages. There is no crossing of moving average by the price or crossing of moving averages between themselves.
In fact, according to the parameters integrated into the Central Analyzer system, 17 technical indicators out of 18 analysed are currently bullish. Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Previous candle closed over Bollinger bands
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : Weekly
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : 1 hour
An analysis of the price chart with the Central Patterns scanner (detector of chart patterns and resistances and supports) shows a result that can have an impact on the price change:
Resistance of channel is broken
Type : Bullish
Timeframe : 1 hour
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 0.2639 | 0.3120 | 0.3460 | 0.3700 | 1.1100 | 1.4513 | 1.7994 |
| Change (%) | -28.68% | -15.68% | -6.49% | - | +200.00% | +292.24% | +386.32% |
| Change | -0.1061 | -0.0580 | -0.0240 | - | +0.7400 | +1.0813 | +1.4294 |
| Level | Major | Minor | Major | - | Minor | Intermediate | Intermediate |
Attention could also be paid to pivot points to set price objectives:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.2435 | 0.2570 | 0.2835 | 0.2970 | 0.3235 | 0.3370 | 0.3635 |
| Camarilla | 0.2990 | 0.3027 | 0.3063 | 0.3100 | 0.3137 | 0.3173 | 0.3210 |
| Woodie | 0.2500 | 0.2603 | 0.2900 | 0.3003 | 0.3300 | 0.3403 | 0.3700 |
| Fibonacci | 0.2570 | 0.2723 | 0.2817 | 0.2970 | 0.3123 | 0.3217 | 0.3370 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.1187 | 0.1713 | 0.2407 | 0.2933 | 0.3627 | 0.4153 | 0.4847 |
| Camarilla | 0.2765 | 0.2876 | 0.2988 | 0.3100 | 0.3212 | 0.3324 | 0.3436 |
| Woodie | 0.1270 | 0.1755 | 0.2490 | 0.2975 | 0.3710 | 0.4195 | 0.4930 |
| Fibonacci | 0.1713 | 0.2179 | 0.2467 | 0.2933 | 0.3399 | 0.3687 | 0.4153 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 0.0957 | 0.1503 | 0.1902 | 0.2448 | 0.2847 | 0.3393 | 0.3792 |
| Camarilla | 0.2040 | 0.2127 | 0.2213 | 0.2300 | 0.2387 | 0.2473 | 0.2560 |
| Woodie | 0.0883 | 0.1466 | 0.1828 | 0.2411 | 0.2773 | 0.3356 | 0.3718 |
| Fibonacci | 0.1503 | 0.1864 | 0.2087 | 0.2448 | 0.2809 | 0.3032 | 0.3393 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 69.51 | |
| MACD (12,26,9): | 0.0146 | |
| Directional Movement: | 26.3501 | |
| AROON (14): | 57.1429 | |
| DEMA (21): | 0.3265 | |
| Parabolic SAR (0,02-0,02-0,2): | 0.2853 | |
| Elder Ray (13): | 0.0434 | |
| Super Trend (3,10): | 0.2942 | |
| Zig ZAG (10): | 0.3650 | |
| VORTEX (21): | 1.1085 | |
| Stochastique (14,3,5): | 81.89 | |
| TEMA (21): | 0.3334 | |
| Williams %R (14): | -13.70 | |
| Chande Momentum Oscillator (20): | 0.0750 | |
| Repulse (5,40,3): | 12.8240 | |
| ROCnROLL: | 1 | |
| TRIX (15,9): | 0.3080 | |
| Courbe Coppock: | 16.02 |
| MA7: | 0.2887 | |
| MA20: | 0.2499 | |
| MA50: | 0.2452 | |
| MA100: | 0.3972 | |
| MAexp7: | 0.3329 | |
| MAexp20: | 0.3102 | |
| MAexp50: | 0.2907 | |
| MAexp100: | 0.2723 | |
| Price / MA7: | +28.16% | |
| Price / MA20: | +48.06% | |
| Price / MA50: | +50.90% | |
| Price / MA100: | -6.85% | |
| Price / MAexp7: | +11.14% | |
| Price / MAexp20: | +19.28% | |
| Price / MAexp50: | +27.28% | |
| Price / MAexp100: | +35.88% |
Quotes :
-
15 min delayed data
-
Euronext Paris
News
Don't forget to follow the news on TME PHARMA. At the time of publication of this analysis, the latest news was as follows:
- TME Pharma N.V.: Half-yearly Report on the Liquidity Contract With Invest Securities
- TME Pharma Provides Positive Data Update on Best Response to Therapy With First Complete Response in GLORIA Trial in Glioblastoma, Bringing 50% of Patients in Expansion Arm to Complete or Near-Complete Response
- TME Pharma Announces Positive 15-month Survival Data From GLORIA Expansion Arm Evaluating NOX-A12 in Combination With Radiotherapy and Bevacizumab in Glioblastoma
- TME Pharma Receives Investigational New Drug (IND) Approval for NOX-A12 From the US FDA
- TME Pharma Announces Convocation of the 2023 Annual General Meeting of Shareholders
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis TME PHARMA - 1H